SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-294632
Filing Date
2020-11-16
Accepted
2020-11-16 15:00:58
Documents
3
Period of Report
2020-11-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d12148d8k.htm 8-K 18481
2 EX-99.1 d12148dex991.htm EX-99.1 14056
3 GRAPHIC g12148g93a38.jpg GRAPHIC 5716
  Complete submission text file 0001193125-20-294632.txt   41665
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 201315852
SIC: 2834 Pharmaceutical Preparations